North America Transfection Reagent and Equipment Market – Industry Trends and forecast period of 2021 to 2030.
North America transfection reagent and equipment market is expected to reach the value of USD 1,319,255.58 thousand by 2030, at a CAGR of 9.9% during the forecast period.
For instance,
World Health Organization (WHO) has provided an estimate that by 2020 almost three- quarters of all death worldwide has been accounted due to chronic diseases.
The centers for disease control and prevention projected that 6 in every 10 adults in the U.S. are suffering from chronic disease.
Data Bridge Market Research analyzes that the Global Transfection Reagent and Equipment Market is expected to grow with a CAGR of 9.6% from 2023 to 2030 and is expected to reach USD 2,284,494.00 thousand by 2030. The reagent and kits segment is projected to propel the market growth as the development of synthetic product is rising worldwide.
Request Access for Free Sample Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-transfection-reagents-and-equipment-market
Surging level of investment in development of innovative transfection instruments
The market players operating their business in transfection are continuously investing their money to achieve the best outcome. These companies are also getting funding from third party sources, boosting their activities. Several types of investments are accelerating the research and developmental activities of the transfection products and by time-to-time, new products are adding on to the existing established market.
For instance,
In April 2020, Polyplus Transfection expanded its partnership with the Warburg Pincus and ArchiMed. Warburg Pincus is one of the equity firm focused on investment. ArchiMed is an equity healthcare specialist who will advance the development and sale of Polyplus' breakthrough solutions. Through this agreement, the company is expected to accelerate the production capacity of several of its major transfection products. This investment allowed the company to access resources form both the companies and to attain a lucrative growth.
The investments done by several companies allowed the development and introduction of new and innovative transfection instruments and reagent in the market. These innovative products have enhanced the transfection efficiency and boosted the manufacturer's credibility in the market. This thus signifies that the surging level of investment is acting as an opportunity for the global transfection reagent and equipment market growth.
Access Full Report: https://www.databridgemarketresearch.com/reports/north-america-transfection-reagents-and-equipment-market
Segments Covered
By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagent and Equipment, Stable Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others).
Countries Covered
U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Switzerland, Russia, Netherlands, Belgium, Turkey, and Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Philippines, Indonesia, and Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt, and Rest of the Middle East and Africa.
Market Players Covered
Mirus Bio LLC. (U.S.), Promega Corporation (U.S.), Polyplus Transfection (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Lonza (Switzerland), MaxCyte, Inc. (U.S.), Altogen Biosystems (U.S.), SBS Genetech, FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation) (U.S.), Avanti Polar Lipids (A Subsidiary of Croda International Plc) (U.S.), PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.) (Germany), Cytiva (Denmark), Geno Technology Inc., USA (U.S.), R&D Systems, Inc. (U.S.), Takara Bio Inc. (Japan), Thermofisher Scientific Inc. (U.S.), Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd), OriGene Technologies, Inc. (U.S.), Applied Biological Materials Inc. (abm)(Canada), Beckman Coulter, Inc. (A Subsidiary of Danaher)(Germany), SignaGen Laboratories (U.S.), Genlantis Inc. (U.S.), Ginkgo Bioworks (U.S.), among others.
Data Points Covered in the Report
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Segment Analysis:
- On the basis of stage, the global transfection reagent and equipment market is segmented into research, preclinical, clinical phases, and commercial. In 2023, the research segment is expected to dominate the market with 67.57% market share and is expected to reach USD 1,587,801.74 thousand by 2030 from USD 741,387.49 thousand in 2022, growing with the CAGR of 10.0% in the forecast period of 2023 to 2030.
- On the basis of type, the global transfection reagent and equipment market is segmented into transient transfection reagent and equipment and stable transfection reagent and equipment. In 2023, the transient transfection reagent and equipment segment is expected to dominate the market with 66.98% market share and is expected to reach USD 1,631,763.86 thousand by 2030 from USD 734,960.99 thousand in 2022, growing with the CAGR of 10.5% in the forecast period of 2023 to 2030.
Get TOC of the Report: https://www.databridgemarketresearch.com/toc/?dbmr=north-america-transfection-reagents-and-equipment-market
North America Transfection Reagent and Equipment Market
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insights
Chapter Six: North America Transfection Reagent and Equipment Market
Browse Related Reports @
- Asia-Pacific Compound Management Market
- Europe Compound Management market
- Middle East and Africa Compound Management market
- North America Compound Management market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email : Sopan.gedam@databridgemarketresearch.com
